SEC Form 4 · accession 0001144204-17-061253
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles M Watts
Director
Period of report
Nov 14, 2017
Accepted (ET)
Nov 28, 2017 · 9:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $19.15 | Nov 14, 2017 | A | 3,887 | A | — | Nov 14, 2027 | Common Stock | 3,887 | 3,887 | D |
| Stock Option (right to buy)F2 | $19.15 | Nov 14, 2017 | A | 29,765 | A | — | Nov 14, 2027 | Common Stock | 29,765 | 29,765 | D |
Explanation of responses
- F1The option vests in 5 equal monthly installments, with the first installment vesting on December 14, 2017.
- F2The option vests in 5 equal annual installments, with the first installment vesting on November 14, 2018.